Abstract Number: 2279 • ACR/ARHP Annual Meeting 2018
Therapeutic Value of Canakinumab in Patients with Yao Syndrome
Background/Purpose: Yao syndrome (YAOS, OMIM 617321), formerly termed nucleotide-binding, oligomerization domain 2(NOD2)-associated autoinflammatory disease, is characterized by periodic fever, dermatitis, arthritis, and swelling of the…
ACR Meeting Abstracts